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Balancing Thymocyte Adhesion And Motility:
A Functional Linkage Between lntegrins
and the Motility ReceptorRHAMM
SHERYL L. GARES and LINDA M. PILARSKI*
Department of Oncology, University ofAlberta and Cross Cancer Institute, Edmonton, AB, Canada
Thymocyte differentiation involves several processes that occur in different anatomic sites
within the thymus. Therefore, thymocytes must have the ability to respond to signals received
from stromal cells and adopt either adhesive or motile behavior. We will discuss our data indi-
cating human thymocytes use c4131 integrin, 5131 integrin and RHAMM to mediate these
activities. Immature multinegative (MN; CD3-4-8-19-) thymocytes use c4131 and e5131
integrins to mediate weak and strong adhesion. This subset also uses e4131 integrin to mediate
motility. As thymocytes differentiate, they begin to express and use RHAMM to mediate
motility in conjunction with x4131 and c5131 integrins. Motile thymocytes use 131 integrins to
maintain weakly adhesive contacts with substrate to provide traction for locomoting cells,
thus weak adhesion is a requirement of motile behavior. Hyaluronan (HA) is also required by
thymocytes’to mediate motility. HA binding to cell surface RHAMM redistributes intracellu-
lar RHAMM to the cell surface where it functions to mediate motility. We propose that the
decision to maintain adhesive or motile behavior is based on the balance between low and
high avidity binding conformations of 131 integrins on thymocytes and that RHAMM:HA
interactions decrease high avidity binding conformations of integrins pushing the balance
toward motile behavior.
Keywords: adhesion, 1 integrins, hyaluronan, motility, RHAMM, thymocytes
Abbreviations:DN, double negative, DP, double positive, ECM, extracellular matrix, FAK, focal adhe-
sion kinase, GAG, glycosaminoglycan, Fn, fibronectin, HA, hyaluronan, HAS, hyaluronan synthase,
MN, multinegative, RHAMM, receptor for hyaluronan-mediated motility, SP, single positive, TCR, T
cell receptor
INTRODUCTION
Development of a diverse peripheral T cell repertoire
able to respond to a broad array of potential patho-
gens, yet tolerant to self depends upon a complex,
orchestrated series of events that occur in the thymus
(for recent reviews see Sebzda et al., 1999; Rodewald
& Fehling, 1998; Fehling & von Boehmer, 1997; Kil-
leen at al., 1998; von Boehmer & Fehling, 1997).
Generation and modeling of the T cell repertoire
begins as thymocyte precursors arrive from the bone
marrow, begin to rearrange T cell receptor (TCR)
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genes and proliferate. Successful TCR gene rear-
rangement is the first critical step in the development
of a functional T cell. Once TCR genes are rear-
ranged and expressed along with CD3, CD4 and CD8,
thymocytes undergo positive and negative selection
before emigrating the thymus to populate the periph-
eral immune system. The outcome of positive and
negative selection (survival or death) is dependent on
signals generated when TCR heterodimers interact
with MHC molecules on thymic stromal cells (Amsen
& Kruisbeek, 1998; Anderson et al., 1996). It is well
recognized that the TCR, MHC class I and II, CD4
and CD8 molecules play a critical role in these inter-
actions (Ellmeier et al., 1999; Sebzda at al., 1999;
Chan et al., 1998; Hedrick & Sharp, 1998; Marrack &
Kappler, 1997). However, interactions of developing
thymocytes with thymic stromal elements; epithelial
cells, dendritic cells, fibroblasts and thymic macro-
phages, also rely upon contacts being made between
additional receptors expressed on thymocytes and
stromal cells during sessile phases of differentiation
(Amsen & Kruisbeek, 1998; Lagrota-Cndido et al.,
1996; Dardenne & Savino, 1994; Savino et al., 1993;
Ritter & Boyd, 1993; Boyd et al., 1993; Watt et al.,
1992; Haynes, 1986).,Although the precise path taken
by thymocytes as they undergo selection is still
unclear, migration must occur within the thymic lob-
ule as thymocytes differentiate; therefore, motility
receptors are also required during migratory phases of
differentiation, ll integrins mediate adhesion and
motility for human thymocytes (Gares et al, 1998;
Salomon et al., 1997; Crisa et al., 1996; Salomon et
al., 1994). The receptor for hyaluronan (HA)-medi-
ated motility (RHAMM) also mediates thymocyte
motility and may function in conjunction with 11
integrins (Gares et al., 1998; Pilarski et al., 1993).
Recently another layer of complexity has been added,
since chemokines and chemokine receptors have beerJ
found to be expressed in the thymus and to mediate
thymocyte chemotaxis. This indicates the mecha-
nisms used by thymocytes to migrate through the thy-
mus are likely to be as complex as those required for
the process of selection. The emphasis of this article
is to present our data and propose a model that
addresses how thymocytes may achieve this task. Our
data indicates [ 1 integrins and RHAMM have a func-
tional relationship within which their expression and
function is balanced between adhesion and de-adhe-
sion to ultimately promote either adhesive or motile
behavior.
TRAFFICKING IN THE THYMUS
Thymic Structure
The thymus is composed of a number of encapsulated
lobules which consist of a subcapsular region, a cor-
tex heavily populated with immature, double positive,
(DP; CD4+8+) thymocytes, nurse cells, macrophages
and epithelial cells and a medulla containing macro-
phages, dendritic cells, medullary epithelial cells and
more mature, single positive, (SP; CD4+8 and CD4-
8+) thymocytes (Boyd et al., 1993; Haynes, 1986;
1984). The medulla also contains thymocytes with the
phenotype expected of a generative thymocyte line-
age (Pilarski, 1993). Phenotypic analysis of thymo-
cytes and thymic epithelial cells has been used to
determine where selective events are likely to occur
in order to track the path of differentiating thymocytes
(van Ewijk et al., 1994; Boyd et al., 1993; Pilarski,
1993; Boyd & Hugo, 1991; Nikolic-Zugic, 1991;
Haynes, 1986). In both mouse and human tissue, the
site of entry of pro-thymocytes has not been defini-
tively determined and may be the cortico-medullary
junction or the subcapsular region. In addition to an
analysis of surface phenotype of thymocytes in the
cortex, in situ assessment of apoptosing cells in
MHC-deficient mice indicates this region is likely to
be the anatomic site of positive selection (Surh &
Sprent, 1994). Thymocytes that are presumably
receiving negative signals can be identified in the
medulla, but these results do not exclude a model in
which negative selection occurs in the cortex and cor-
tico-medullary junction, with the consequences of
negative selection (apoptosis) occurring in the
medulla. It is likely positive and negative selection
are ongoing processes in which each differentiating
thymocyte makes a series of contacts with a variety of211
MHC-peptide complexes on numerous stromal cells
before a thymocyte is able to fully mature. This model
of differentiation emphasizes the requirement for thy-
mocytes to rapidly respond to microenvironmental
cues by regulating the function of adhesion and motil-
ity receptors while they are within one compartment
of the thymus lobe as well as when they migrate to an
anatomically distinct site within the thymus.
Extracellular matrix (ECM) components within the
human thymus include fibronectin (Fn), laminin, col-
lagens, glycosaminoglycans (GAGs) (Savino et al.,
1993; Berrih et al., 1985) and merosin (Chang et al.,
1993). In addition to the contacts made between thy-
mocytes and stromal cells, these constituents likely
play a role during thymocyte differentiation by main-
taining adhesive contacts during sessile phases of
development and promoting motility during migra-
tory phases of development. Fn mediates proliferation
and adhesion for murine thymocytes (Halvorson et
al., 1998; Sawada et al., 1992; Utsumi et al., 1991)
and both adhesion and motility for human thymocytes
via c41 and51 integrins (Gares et al, 1998; Salo-
monet al., 1997; Crisa et al., 1996; Salomon et al.,
1994), whereas merosin mediates only adhesion of
mouse and human thymocytes via c6[1 integrin
(Chang et al., 1993). Neither we, nor others have
found thymocytes adhere to laminin-, vitronectin- or
collagen-coated surfaces. HA is a ubiquitously
expressed GAG of the ECM and is a large polysac-
charide consisting of repeating dimers of glucuronate
and N-acetylglucosamine. HA plays a structural role
in ECM providing turgor pressure in tissue spaces and
acts as a cushion in joints, but smaller fragments of
HA have been shown to mediate a number of cellular
effects upon interaction with HA binding proteins or
hyaladherins (for reviews see Borland et al., 1998;
Fraser et al., 1997; Toole, 1997; Entwistle et al., 1996;
Sherman et al., 1994; Knudson & Knudson, 1993).
HA mediates motility, endocytosis, signal transduc-
tion and cytokine secretion upon interaction with the
hyaladherins RHAMM and CD44. Human thymo-
cytes express both RHAMM and CD44, but
RHAMM:HA interactions appear to be predominant
in the motile process.
[1 Integrin-mediated Adherence and Motility
The expression of [1 integrins in other developing
tissues suggested there might be a correlation of
integrin expression and function with stages of thy-
mocyte differentiation. Immunohistochemical stain-
ing of human thymus as well as staining of thymocyte
suspensions and thymic epithelial cultures indicates a
number of adhesion receptors are expressed on both
cell types with especially strong representation of 1
and 2 heterodimers (Watt et al., 1992). Immunohis-
tochemical analysis of human thymus also indicates
collagens, Fn and laminin are distributed within the
thymus (Berrih et al., 1985; Savino et al., 1993). In
vitro experiments indicate ECM constituents influ-
ence the growth of thymic epithelial cells, thus are
"active" components of the thymic microenviron-
ment. Analysis of the adhesion of murine double neg-
atives (DN; CD4-8-) indicates these thymocytes
spontaneously adhere to Fn-coated plates and to
Fn-treated stromal cell monolayers utilizing c4 pre-
dominantly and5 integrin to a lesser extent (Sawada
et al., 1992; Utsumi et al., 1991). Antibody or peptide
blocking of these interactions inhibits in vitro differ-
entiation of DN thymocytes to the DP stage. Further
subset analysis indicates c4 expression decreases as
thymocytes mature to the DP and SP stages. This
work indicates differentiating thymocytes express
constitutively active conformations of [1 integrins
and suggests integrins play a role in differentiation.
Multinegative (MN; CD3-4-8-19-) human thymo-
cytes purified by negative selection methods contain a
similar proportion of Fn-adherent cells and Mabs to
4, c5 and [1 block adherence, again indicating
c4ll and 511 integrins mediate interaction of
immature thymocytes with thymic stroma or ECM
components (Gares et al., 1998). Although murine DP
and SP thymocytes downregulate4 integrin expres-
sion, human thymocytes continue to express and uti-
lize c4[1 as well as 51 as they undergo
differentiation. Fn-adherent thymocytes utilizing
c4[1 have a phenotype consistent with DP cells that
have not yet received a positive selection signal
(CD4hi8hi3me691) (Salomon et al., 1994).
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thymocytes with a "post-selection" phenotype
(CD4med8med3hi69hi) indicating the non-adherent
fraction contains more mature cells. However, c4
expression of these thymocytes is equivalent to that of
less mature DP thymocytes, suggesting lack of adhe-
sive behavior is a result of downregulation of ,’
function. These experiments indicate a correlation of
integrin function with thymocyte differentiation and
led to a model proposing that4 facilitates interac-
tion of thymocytes with cortical epithelial cells during
positive selection. One of the consequences of posi-
tive selection appears to be an alteration of c4l 1 to an
inactive conformation causing de-adherence enabling
thymocyte migration to the medulla.
The 41 and 51 integrins also function as
mediators of motility for human thymocytes (Gares et
al., 1998; Crisa et al., 1996). MN thymocytes utilize
c4 to mediate motility and more mature DP and SP
thymocytes use a combination of 4[1, 51 and
RHAMM to mediate motility. This interplay of
integrins and RHAMM will be more fully discussed
in subsequent sections.
Chemokines and Chemokine Receptors
In the last two years a number of chemokines and
chemokine receptors have been detected in both
murine and human thymus tissue. To date, thymo-
cytes express the chemokine receptors CCR3, CCR5,
CCR7, CXCR4 and GPR-9-6 (proposed name CCR9)
and expression and function of these receptors corre-
lates with developmental subsets of thymocytes. This
suggests chemokines and chemokine receptors play a
role in trafficking through the thymus that is likely
related to selection signals received during differenti-
ation.
The orphan chemokine receptor GPR-9-6 has been
characterized as the receptor for the thymus expressed
chemokine TECK (Zaballos et al., 1999). GPR-9-6
mRNA is expressed in immature and mature human
and murine thymocytes and cell lines transfected with
GPR-9-6 are chemotactic in response to TECK.
Thymic dendritic cells produce TECK, so it is specu-
lated that GPR-9-6 may be utilized by thymocytes
through all stages of differentiation to mediate chem-
otaxis. CXCR4 is also expressed on immature
CD34+TCR human thymocytes (Zaitseva et al.,
1998) and mRNA transcripts encoding murine
CXCR4 are detected among the immature
CD44+25+4-8 subset (Suzuki et al., 1999). CXCR4
expression is downregulated on more mature SP sub-
sets. The ligand of CXCR4, stromal cell-derived fac-
tor-1 (SDF-1) mediates Ca2+ flux and chemotaxis of
immature DN and DP thymocytes and is expressed by
cortical stromal cells suggesting a role for this chem-
okine in early thymocyte differentiation
CCR5 is weakly expressed by human thymocytes
with the exception of the CD34+TCR subset, which
shows high expression of both CXCR4 and CCR5
(Zaitseva et al., 1998). However, this group did not
find CCR5 ligands (RANTES, MIP-lc, MIP-1)
Stimulated chemotaxis or Ca2+ flux of human thymo-
cytes. Another group reported MIP-I[ supported
chemotaxis of all human thymocytes except the DN
subset and chemotactic activity of these subsets corre-
lated with the expression of CCR5 (Dairaghi et al.,
1998). These contrasting results indicate chemok-
ine-mediated migration in relation to thymic differen-
tiation is likely to be an extremely complex series of
events to decipher.
Chemokine receptors expressed by more mature
thymocyte subsets include CCR3, CCR4 and CCR7.
Murine CD4+8+69+ thymocytes, a subset that has
putatively undergone positive selection, express
CCR4 mRNA transiently which is replaced by
expression of CCR7 as thymocytes mature to SP cells
(Suzuki et al., 1999). Ligands for these two chemok-
ine receptors, including thymus-expressed chemok-
ine, TARC and ELC, are expressed in the medulla
suggesting a role in trafficking of more mature thy-
mocytes. Mature CD8+ SP cells express CCR3 and
one of its ligands, eotaxin, is expressed in the thymic
medulla (Franz-Bacon et al., 1999). However, eotaxin
causes chemotaxis of both DP and SP subsets con-
trary to the lack of detectable expression of CCR3 on
DP and CD4+ SP cells. As more is learned about
chemokines and their role in thymic migration, it will
be of interest to determine how they function in rela-
tion to other adhesion and motility receptors.213
RHAMM and HA
RHAMM was originally isolated as a HA-binding
protein from locomoting chick heart fibroblasts (Tur-
ley, 1989) and subsequent molecular cloning indi-
cated the nucleotide sequence is distinct from the HA
binding protein, CD44 (Hardwick et al., 1992).
Examination of a number of developing tissues in
which cells are required to be migratory indicates
RHAMM is expressed and functions as a motility
receptor (Pilarski et al., 1999; Gares et al., 1998;
Nagy et al., 1995; Kornovski et al., 1994; Pilarski et
al., 1993; Boudreau et al., 1991; Turley at al., 1990).
RHAMM is also over-expressed by malignant cells
isolated from multiple myeloma patients and human
breast tumors (Crainie et al., 1999; Wang et al., 1998).
Transfection of fibroblasts with RHAMM causes
non-tumorigenic cells to become highly tumorigenic
which implicates RHAMM as a potent oncogene and
emphasizes the importance of this receptor as a medi-
ator of motility (Hall et al., 1995).
Sequence analysis of genomic murine RHAMM
indicates the RHAMM gene is comprised of 14 exons
and similar to CD44, splice variants are observed
(Entwistle et al., 1995). Recently, four additional
exons have been identified in the open reading frame
of the murine RHAMM gene (Fieber et al., 1999).
Three different species of RHAMM transcripts have
also been isolated from human B and plasma cells of
multiple myeloma patients (Crainie et al., 1999). Two
of the three transcripts contain deleted regions corre-
sponding to transcriptional excision of exons, but the
functional significance of these variant transcripts is
unknown. At the protein level, immunoblots indicate
ex vivo cells and various cell lines express RHAMM
of two or three different apparent molecular weights
(Wang et al., 1996; Nagy et al., 1995; Kornovski et
al., 1994). As yet, it is unknown whether the variable
size of RHAMM is due to translation of splice vari-
ants, variation in carbohydrate addition, phosphoryla-
tion or a combination of these processes.
Murine and human RHAMM sequences are highly
conserved with the majority of sequence variation
occurring in the amino terminus (Wang et al., 1996).
RHAMM also contains two translation start codons.
Translation of human RHAMM mRNA from the + 1
position would give rise to a 726 aa protein, whereas
translation from the second start codon would yield a
protein of 610 aa. Variant usage of these start codons is
currently being investigated and could provide another
explanation for the size variation ofRHAMM proteins.
The HA binding motif was characterized using a
RHAMM expression system and consists of two basic
amino acids with an intervening span of seven
non-acidic amino acids (BX7B) (Yang et al., 1994;
1993). HA binding is optimal if at least one of the inter-
vening residues is also basic. RHAMM contains two
HA binding motifs near the carboxy end of the protein
that are encoded by exons 12 and 13. HA binding to
both domains appears to be additive, thus the two HA
binding domains apparently function independent of
one another. This HA binding motif has also been iden-
tified in the hyaladherins CD44 and link protein, thus
may be a universally used HA binding motif.
Consistent with the role of RHAMM as a motility
receptor, motile cells express cell surface RHAMM as
indicated by FACScan analysis and both fluorescent
and confocal microscopy (Pilarski et al., 1999; Crainie
et al., 1999; Masellis-Smith, et al., 1996; Nagy et al.,
1995; Kornovski et al., 1994; Pilarski et al., 1993).
However, there is also substantial expression of an
intracellular form of RHAMM (Gares et al., under
revision; Pilarski et al., 1999; Assmann et al., 1998;
Hofmann et al., 1998; Nagy et al., 1995). Various
model systems indicate RHAMM-mediated motility
can occur very rapidly (between to 6 H) following
wounding or subculture of cell lines (Savani et al.,
1995; Turley, 1992). The addition of HA also rapidly
upregulates cell motility which can be blocked by
RHAMM-specific antibody. This rapid adaptation of
cells to a change in their microenvironment suggests
HA may modulate RHAMM expression and cell
behavior. We have chosen to further explore this inter-
action using ex-vivo human thymocytes. We hypothe-
sized that developing cells such as thymocytes require
motility receptors during migratory phases of develop-
ment. Since a number of differentiating cell types
express RHAMM, we reasoned RHAMM might be a
likely candidate to mediate motile behavior for thymo-
cytes. We will describe our work to date and put for-
ward a model of how RHAMM interacts with
integrins and HA to mediate motility.214 SHERYL L. GARES and LINDA M. PILARSKI
[31 lntegrins in High Avidity
Conformations Promote Sessile
Behavior
[31 Integrins in Low Avidity
Conformations Promote
Motile Behavior
@High avidity c4[ integrin 1
@High avidity t5[ integrin 1
555 Fn
)Low avidity c4[ 1 integrin
Low avidity c5[ 1 integrin
RHAMM
FIGURE The Balance Between Adhesion and Motility is Mediated by Integrin Avidity. When 4[ and5 are in high avidity binding
conformations, human thymocytes adhere strongly to Fn and sessile behavior predominates. HA binding to RHAMM may initiate signals
that alter integrins to low avidity binding conformations. Integrins then maintain weakly adhesive contact with Fn, which promotes motile
behavior. Thymocytes can revert to either behavior depending on signals received from stromal cells or the microenvironment during differ-
entiation
A BALANCE EXISTS BETWEEN ADHESION
AND MOTILITY
Interactions Between 1 Integrins And RHAMM
FACScan analysis of unfractionated ex-vivo human
thymocytes stained with anti-RHAMM monoclonal
antibodies (Mabs) indicates RHAMM is expressed at
low density by a subset of thymocytes, the majority of
which express a moderate to high level of CD3 (Pilar-
ski et al., 1993). To determine ifRHAMM expression
correlates with developmental subsets of thymocytes
based upon expression of CD4 and CD8, three color
staining was done. Although MN thymocytes did not
express RHAMM, both DP and SP subsets contain
RHAMM+ cells. Analysis of the motility of DP cells
(CD4+8+ or CD3med) and SP cells (CD4+CD8-,
CD4-CD8+ or CD3hi) using video time-lapse micros-
copy indicates both DP and CD4+ SP subsets contain
motile cells and Mabs to RHAMM significantly
inhibit motility as do Mabs to c4, c5 and [ 1 integrins
(Gares et al., 1998). However, Mabs to CD44 have no
effect on motility. Although the extent of inhibition
by Mabs to integrins or RHAMM is comparable,
using video time-lapse microscopy to quantitate
motility by observing cellular behavior, we detect a
qualitative difference in the blocking activity of the
RHAMM Mabs versus the Il integrin Mabs.
Anti-RHAMM Mabs inhibit motility, but cell adher-
ence is unaffected or increased. Function blocking
Mabs to the [ 1 integrin components cause the cells to
be non-adherent, suggesting [1 integrins are required
by motile thymocytes to make weak adhesive con-
tacts with substrate, providing traction for locomoting215
cells. Adhesion and motility may be viewed as oppos-
ing cellular behaviors in which adhesion receptors are
operational while cells remain sessile and are
non-functional while cells are motile. However, these
observations suggest instead that adhesion receptors
remain functional while cells are motile. Strong adhe-
sive contacts must be "broken" to enable a cell to
begin to locomote. Therefore, one of the requirements
of motility is to decrease strong adhesion. A motile
cell still requires contacts with substrate while
re-organizing all the cellular machinery required for
movement and weak adhesive contacts may be
required for motility receptors to function. This
implies motile behavior is dependent on the balance
between strongly adhesive and weakly adhesive con-
tacts. Thus, increasing the avidity of integrin binding
should cause cells to become less motile. To test this
possibility, we used a Mab to 1]1 integrin that, upon
binding, forces the integrin into a high avidity binding
conformation (Gares et al., 1998). Thymocytes
pre-treated with this Mab are less motile and have a
concomitant increase in adhesion. This indicates that
strong adhesion by integrins is dominant over
RHAMM-mediated motility. Forcing [1 integrins
into the high avidity binding conformation tips the
balance in favor of adhesion. The corollary of this is
that to maintain motility, thymocytes must decrease
high avidity integrin interactions between stromal ele-
ments and ECM. It is possible that RHAMM-medi-
ated signaling may cause integrins to alter to low
avidity binding conformations or that separate signals
alter integrin function andRHAMM expression main-
tains this state (Fig. 1). HA binding to RHAMM
causes net de-phosphorylation of focal adhesion
kinase (FAK) (Hall et al., 1994), which reduces the
adhesiveness of focal adhesions, thus one function of
RHAMM may be to maintain low avidity integrin
binding conformations.
This hypothesis implies a functional relationship
exists between integrins and RHAMM. To character-
ize this relationship experimentally, we examined
expression and function of these receptors at an early
point in differentiation prior to detectable RHAMM
expression (Gares and Pilarski, 1999). MN thymo-
cytes were purified using bead depletion or bead
depletion in combination with cell sorting to remove
CD3+4+8+19+ cells. FACS analysis of these cells
showed a lack of RHAMM expression, but moderate
expression of c4, o5, a6 and 1 integrin subunits.
MN thymocytes were then cultured on uncoated or
Fn-coated tissue culture wells over a period of several
days and expression of RHAMM and integrin subu-
nits was monitored over time. MN thymocytes cul-
tured in vitro for two days, upregulate expression of
the 1 integrin subunits and RHAMM in the presence
or absence of Fn. This suggests thymocytes undergo-
ing in vitro differentiation become migratory and
likely use RHAMM to mediate migratory behavior at
this point in development. Although Fn is not
required to upregulate short term RHAMM expres-
sion, thymocytes cultured for longer periods (up to
day 5 or 7) maintain RHAMM expression only in the
presence of Fn. This implies prolonged RHAMM
expression may be dependent upon signals mediated
by integrins binding to their ligand. Alternatively,
RHAMM may interact directly or indirectly with Fn
to maintain expression. To test whether strong adhe-
sive contacts of integrins affect RHAMM expression,
MN thymocytes were cultured in Fn-coated wells
containing immobilized Mabs to c4, a5, or 1
integrins. Prolonged RHAMM expression is inhibited
when Fn-coated wells contain these immobilized
Mabs. Control Mabs or anti-RHAMM Mabs do not
affect the prolonged expression of RHAMM. Immo-
bilized, function-blocking Mabs to each of these
integrin components also decreased RHAMM mRNA
expression. This data indicates strong adhesion (emu-
lated by integrin binding to immobilized Mabs) medi-
ated by c4ll and o51 is not only dominant over
RHAMM-mediated motility as previously discussed,
but also that strong adhesion actually inhibits
RHAMM expression. By extrapolation, the alteration
of sessile behavior by decreasing integrin avidity
must rely on a RHAMM-independent mechanism, at
least at this stage of development. Since chemokine
receptors are operational at this stage of development
and stromal cells secrete chemokines, these receptors
may function to decrease integrin avidity.
Since RHAMM expression is upregulated in the
presence or absence of Fn, this suggests MN thymo-216 SHERYL L. GARES and LINDA M. PILARSKI
MN Thymocytes Use lntegrins to
Promote Adhesion or Motility
CD3fICR
+ Thymocytes Use Integrins
and RHAMM to Mediate Motility
fferentiation
rentiation
Fn
nigh avidity c4[1 integrin HA Low avidity ct4[l integrin
High avidity c[l integrin RHAMM Low avidity 5[ 1 integrin
FIGURE 2 Differentiation ofMN Thymocytes Correlates With Low Avidity Binding Conformations of41, c5[1 and Onset ofRHAMM
Expression. High avidity binding conformations of 4[1 and c5[1 integrins maintain sessile behavior for human MN thymocytes by medi-
ating strong binding to the ECM component Fn (as shown) or to stromal cells.4 integrins in low avidity binding conformations mediate
motility for MN thymocytes by mediating weal< adhesive contacts with ECM components. Highly adhesive MN thymocytes might be at a
different developmental stage than motileMN thymocytes, but the sequence in development is unknown at this time. As MN thymocytes dif-
ferentiate and express CD3+, they begin to express RHAMM. HA binding to RHAMM mediates motility. Integrins are then maintained in
low avidity binding conformations to mediate weak adhesive contacts with the ECM and provide traction for locomoting thymocytes
cytes receive signals in vivo to become migratory. The
requirement for Fn to maintain RHAMM expression
suggests RHAMM expression and presumably func-
tion, is dependent upon integrin interactions with sub-
strate. This interaction is likely via weak adhesive
contacts. It also suggests integrins function either
directly or indirectly to regulate locomotory behavior
by controlling RHAMM expression.
To assess the function of integrins and RHAMM,
MN thymocytes and cultured thymocytes were
pre-treated with Mabs to integrin subunits or
RHAMM followed by analysis of adhesion and motil-
ity using video time-lapse microscopy. Using this
experimental system we believe both weak and strong
adhesion are measured. MN thymocytes contained
31% adherent cells and 40% motile cells. Mabs to 1 1
and4 significantly inhibit both adhesion and motil-
ity indicating 4[ is the major mediator of adhesion
and motility for undifferentiated thymocytes.
Anti-RHAMM Mabs do not inhibit adhesion or motil-
ity correlating with the lack of detectable RHAMM
expression and verifying motility of MN thymocytes
is RHAMM independent. Using a fluorescence-based
adherence assay in which thymocytes adhere and areHA Binds Surface RHAMM-9
sRHAMM-9
iRHAMM-5
B. iRHAMM-5 Redistributes to the Cell Surface
C. sRHAMM-9 and sRHAMM-5 Mediate Motility
FIGURE 3 HA Binding Redistributes iRHAMM-5 to the Cell Surface Where It Becomes A Participant in Motility. Thymocytes express a
low density of sRHAMM-9 and a higher density of iRHAMM-5. Prior to HA binding to sRHAMM-9, integrins may bind Fn with high avid-
ity and maintain sessile behavior for thymocytes (A). HA binding to sRHAMM-9 initiates signals that result in a redistribution of
iRHAMM-5 to the cell surface and conversion of integrins to low avidity binding conformations (B). At the cell surface, sRHAMM-5 asso-
ciates with sRHAMM-9 to form HA binding complexes that mediate motility. Low avidity binding conformations of integrins mediate weak
adhesive contacts with Fn that provide traction for the locomoting thymocytes (C)218 SHERYL L. GARES and LINDA M. PILARSKI
then subjected to strong shear forces produced by
pipetting, we found Mabs to a4 and [1 also inhibit
strong adhesion, but in contrast to the results of the
video time-lapse analysis, Mabs to o5 also inhibit
adherence. We have interpreted this to mean that
binding to a5 by this particular Mab does not inter-
rupt adhesive contacts with ligand when shear forces
are low. When an adhesion assay is used that incorpo-
rates strong shear forces to remove non-adherent and
weakly adherent cells, Mabs to o5 inhibit adhesion
indicating this epitope is required to make contact
with ligand to maintain strong adhesion by cz5131.
Therefore, MN thymocytes use o5131 to maintain
strong adhesion in combination with o41, o4131 is
also used by MN thymocytes to mediate motility.
Alternatively, cz4131 may mediate motility in conjunc-
tion with an unidentified motility receptor.
We also assessed the motility of differentiated MN
thymocytes by culturing MN cells on Fn-coated
plates for two days. At this stage of thymocyte devel-
opment, motility is now inhibited by anti-RHAMM
Mabs. By day 2 of culture, thymocytes also express
CD3/TCR, indicating that differentiation of thymo-
cytes correlates with RHAMM expression and func-
tion. These experiments may reflect how low and
high avidity integrin interactions operate in the thy-
mus at early stages of differentiation (Fig. 2). In terms
of thymocyte development, interaction of integrins
with ligands expressed by stromal elements or ECM
may regulate cell behavior by altering integrin con-
formations. Integrins on thymocytes may be held in
high avidity conformations during stromal interac-
tions to prolong contact such that thymocytes receive
selection signals or growth factors. Integrins may be
in a low avidity binding conformation when in con-
tact with ECM to promote migration in cell-free areas
of the thymus. Cortical epithelial cells express
VCAM and it has been proposed interactions between
o4131 on thymocytes and VCAM on stromal cells is a
high avidity interaction associated with sessile behav-
ior by thymocytes as they undergo positive selection.
Interaction of o4131 with Fn is a lower avidity interac-
tion likely to support migration (Salomon, et al.,
1997). The immobilized anti-integrin Mabs may
mimic the high avidity interactions of thymocytes
with stromal elements that function to "suppress" the
initiation of motile behavior by inhibiting RHAMM
expression. MN thymocytes likely remain sessile as
they rearrange TCR genes, but TCR[3 expression
leads to a burst of proliferation, which presumably
requires a decrease in high avidity interactions of pro-
liferating cells with stromal cells. RHAMM expres-
sion may be initially upregulated at this point in
development, then maintained by low avidity interac-
tions of integrins with Fn. Once RHAMM is
expressed, HA binding with RHAMM might also
function to maintain low avidity integrin binding,
since HA binding to RHAMM causes a net dephos-
phorylation of FAK. However the initial decrease in
integrin avidity occurs prior to RHAMM expression,
since o4131 integrin mediates motility, perhaps with
another unidentified receptor, prior to RHAMM
expression.
Interaction OfRHAMM With HA
The ability of integrins to shift between low and high
avidity binding conformations enables a cell to rap-
idly alter cellular behavior. If RHAMM function is
related to integrin function, RHAMM may also be
expressed in a manner that enables rapid adaptation to
microenvironmental cues. To study this we have
examined the expression and function ofRHAMM in
response to HA.
We used two different anti-RHAMM Mabs, 3T3-5
and 3T3-9, to stain thymocytes (Gares et al., submit-
ted). The epitope ofRHAMM detected by Mab 3T3-
9 is expressed at low density on the cell surface of 30
to 60% of thymocytes. When thymocytes are stained
sequentially with Mab 3T3-9 then HA conjugated to
FITC (HA-FITC) and examined by confocal micros-
copy, there is co-localization ofRHAMM expression
at sites of HA-FITC binding. CD44 is expressed by
human thymocytes, but HA binding does not correlate
strongly with sites of CD44 expression. This suggests
RHAMM is the predominant cell surface HA binding
receptor used by human thymocytes.
A second anti-RHAMM Mab, 3T3-5, demon-
strates very low to negligible surface binding to thy-
mocytes. However, both anti-RHAMM Mabs bind219
almost equivalently to a RHAMM fusion protein as
assessed by an ELISA. Cell surface RHAMM may
lack or conceal the epitope of Mab 3T3-5. Alterna-
tively, these two Mabs may recognize RHAMM
epitopes expressed by alternate isoforms ofRHAMM.
Several reports indicate cells express an intracellular
form of RHAMM (Pilarski et al., 1999; Hofmann et
al., 1998; Assmann et al., 1998; Nagy et al., 1995). To
determine if thymocytes express intracellular
RHAMM, cells were permeabilized, then stained with
anti-RHAMM Mabs. FACScan analysis and confocal
microscopy indicate Mab 3T3-5 binds an intracellu-
lar form of RHAMM expressed by thymocytes that
we have arbitrarily named iRHAMM-5 (intracellular
RHAMM bound by Mab 3T3-5). Approximately 70%
of thymocytes express iRHAMM-5 and all
iRHAMM-5+ cells are CD3+. Mab 3T3-9, which
binds cell surface RHAMM and which we have
named sRHAMM-9 (cell surface RHAMM bound by
Mab 3T3-9) did not stain permeabilized thymocytes
suggesting this epitope is destroyed by permeabiliza-
tion. Analysis of the predicted amino acid sequence of
human RHAMM by various motif search programs
predict RHAMM is an intracellular protein. The
amino acid sequence ’contains no obvious signal
sequence or transmembrane domain, although there is
abundant evidence that RHAMM is expressed at the
cell surface of normal and transformed cells (Pilarski
et al., 1999; Crainie et al., 1999; Dowthwaite et al.,
1998; Teder et al., 1995; Masellis-Smith et al., 1996;
Nagy et al., 1995; Pilarski et al., 1993). Rat and
human carcinoma cell lines express iRHAMM and
the groups involved with this work have speculated
iRHAMM functions as an intracellular HA binding
receptor (Assmann et al., 1998; Hofmann et al.,
1998). Permeabilized thymocytes stained sequentially
with Mab 3T3-5 then HA-FITC and examined by
confocal microscopy show a co-localization of HA
binding with sites of iRHAMM-5, suggesting that in
thymocytes, iRHAMM-5 may function in this capac-
ity. Endocytosed HA mediates numerous cellular
functions and iRHAMM-5 may participate in intrac-
ellular trafficking of HA. However, RHAMM is also
clearly expressed on the cell surface of thymocytes
and many other cells, but the mechanism of surface
expression is still unknown. RHAMM has previously
been reported to exist in a multimer called HARC
(HA receptor complex) (Turley, 1992). The identity
of all components of this complex is unknown, but
interaction of RHAMM with other membrane or
transmembrane proteins may enable surface expres-
sion of RHAMM. Alternatively, sRHAMM may be
expressed as a gpi-anchored protein.
Preliminary experiments were done to determine if
HA binding affects surface expression of RHAMM.
Intact thymocytes were pre-treated with soluble
HA-FITC then stained with Mabs to RHAMM. Stain-
ing patterns of Mab 3T3-9 are indistinguishable
between HA-treated and untreated thymocytes indi-
cating HA does not block the binding site of this Mab
nor does HA detectably affect expression of
sRHAMM-9. Surprisingly, HA pre-treatment resulted
in detection of cell surface RHAMM by Mab 3T3-5.
Two explanations seem possible. HA binding may
cause a conformational change of sRHAMM-9
revealing the epitope of Mab 3T3-5 without altering
the epitope of Mab 3T3-9. Alternatively, thymocytes
may express two isoforms of RHAMM that function
differently in response to HA binding. Mab 3T3-5
stains a greater number of HA-treated thymocytes
with a greater intensity of staining than can be
accounted for by the low density of sRHAMM-9
expression. This indicates HA binding increases the
number of RHAMM+ cells and increases the density
of RHAMM expressed at the cell surface as detected
by Mab 3T3-5. This might be achieved by a redistri-
bution of iRHAMM-5 to the cell surface. As depicted
by Fig. 3A, thymocytes express a low density of
sRHAMM-9 at the cell surface and an intermediate
density of intracellular iRHAMM-5. Thus, staining of
intact thymocytes with anti-RHAMM Mabs indicates
that, on the cell surface, thymocytes are RHAMM-9+
and RHAMM-5-. HA binding to sRHAMM-9 gener-
ates signals that cause redistribution of iRHAMM-5
to the cell surface (now sRHAMM-5) enabling bind-
ing by Mab 3T3-5 (Fig. 3B and 3C) such that the sur-
face phenotype of HA-treated thymocytes is
RHAMM-9+ and RHAMM-5+. Consistent with this
model, a large proportion of thymocytes express
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the cell surface would account for the increased
number of sRHAMM+ cells and the overall increase
of receptor density at the cell surface.
This model proposes that thymocytes maintain an
intracellular store ofRHAMM that is unable to medi-
ate motility unless redistributed to the cell surface by
appropriate microenvironmental cues. Potentially, this
would enable cells to rapidly alter from sessile to
motile behavior presumably in response to signals
received during differentiation. A prediction of this
model is thatHA should be required to mediate motil-
ity and iRHAMM-5 should mediate motility when
redistributed to the cell surface. Surprisingly, the
number of motile thymocytes is approximately 18%
on Fn-coated wells in the presence or absence of HA.
Using wells coated only with HA, motility is almost
negligible, again indicating thymocytes require con-
tact with Fn to mediate motility. To understand how
thymocytes mediate RHAMM-mediated motility in
the absence of exogenous ligand, we hypothesized
that thymocytes may synthesize their own HA. To test
this hypothesis, thymocytes were pre-treated with
hyaluronidase to remove endogenous HA and motil-
ity was assessed on Fn-coated wells in the absence or
presence of exogenous HA (Gares et al., 1998).
Motility is ablated when thymocytes are pre-treated
with HAase, but addition of exogenous HA restores
motile behavior. This indicates HA is required to
mediate random motility for thymocytes and that thy-
mocytes synthesize their own HA. Hyaluronan syn-
thase (HAS) synthesizes HA at the inner surface of
the plasma membrane and extrudes the polysaccha-
ride externally during synthesis. Three mammalian
HAS genes have been identified (Spicer et al., 1997;
1996; Itano & Kimata, 1996; Watanabe &
Yamaguchi, 1996; Klewes et al., 1993) and we have
found human thymocytes express mRNA for at least
one of these enzymes. We are currently examining the
expression of HAS among different thymocyte sub-
sets to determine if HAS expression correlates with
differentiation of the thymocytes. The observation
that thymocytes have the potential to synthesize their
own HA is provocative and suggests differentiating
thymocytes do not just respond to their microenviron-
ment, but participate in creating a microenvironment
likely to promote RHAMM-mediated motility. It also
predicts RHAMM is likely to be in close physical
proximity to HAS. Thus, once RHAMM and HAS are
expressed, they may function in conjunction with
integrins to push the behavioral balance toward
migration (Fig. 1).
To determine if both sRHAMM-9 and sRHAMM-5
participate in motility, thymocytes were pre-treated
with anti-RHAMM Mabs, washed and motility was
assessed on Fn-coated wells in the presence or
absence of HA (Gares et al., submitted). Mab 3T3-9
significantly inhibits motility in the presence or
absence ofHA indicating sRHAMM-9 is a functional
mediator of motility. IfHA binding to sRHAMM-9 is
required, endogenous HA must be synthesized in suf-
ficient quantity to function in mediating motility. This
again implies HAS may be in close physical proxim-
ity to sRHAMM. In contrast, Mab 3T3-5 decreases
motility marginally in the absence of exogenous HA,
but inhibits motility almost completely in the pres-
ence of HA. This corresponds to the expression data
indicating redistribution of iRHAMM-5 to the cell
surface requires an exogenous source of HA. The
redistribution ofiRHAMM-5 must require high levels
of HA and in our experimental system, this can only
be achieved when exogenous HA is added. Once at
the cell surface, sRHAMM-5 participates in motility.
These experiments indicate both sRHAMM-9 and
sRHAMM-5 mediate motility and both forms of
RHAMM are required for motility, since Mabs to
either form ofRHAMM significantly decrease motil-
ity. Mab binding does not block HA binding to
RHAMM, therefore the inhibition of motility by Mab
binding interferes with other functions of RHAMM.
Binding patterns of the two anti-RHAMM Mabs sug-
gest thymocytes express two functionally distinct iso-
forms of RHAMM. PCR analysis also indicates
thymocytes express transcripts for two isoforms of
RHAMM and additional work is underway to deter-
mine whether these transcripts translate into proteins
with the properties we have described.221
Do Thymocytes Express Two RHAMM lsoforms?
sRHAMM-9 and iRHAMM-5 localize to the cell sur-
face and an intracellular site, respectively, in
untreated ex-vivo thymocytes, implying thymocytes
express two isoforms ofRHAMM and each performs
different functions for cells. The staining patterns by
the two Mabs are also consistent with the expression
of two RHAMM isoforms, since staining patterns
indicate the two forms of RHAMM express different
epitopes. HA pre-treatment of thymocytes enables
Mab 3T3-5 to bind cell surface RHAMM which is
consistent with a different, intracellular isoform of
RHAMM being redistributed to the cell surface. In
addition, HA pre-treatment does not increase surface
staining by Mab 3T3-9. Binding by HA is not
expected to affect either Mab binding to their respec-
tive epitopes, since confocal analysis indicates both
RHAMM isoforms can be dual stained with Mab
3T3-5 or 3T3-9 and HA-FITC.
However, sRHAMM-9 and iRHAMM-5 could be
genetically identical, but occur in both cellular com-
partments as a consequence of endocytosis of HA.
RHAMM-mediated endocytosis of HA has been
reported (Collis et al., ’1998; Masellis-Smith et al.,
1996) and internalized sRHAMM-9 could contribute
to the intracellular pool of RHAMM that we have
identified as iRHAMM-5. Receptor recycling could
also account for the presence ofRHAMM in both cel-
lular compartments. We have tested the possibility
that sRHAMM is a gpi-anchored protein. Thymocytes
were pre-treated with phosphoinositol-specific phos-
pholipase C (PLC) followed by analysis of motility
on Fn-coated wells in the absence or presence of
exogenous HA (Gares et al., submitted). Motility of
PLC-treated thymocytes is ablated if behavior is
assessed in the absence of exogenous HA. However,
if exogenous HA is present, motility is restored and
PLC-treated cells contain the same number of motile
cells as untreated controls. The ability of PLC treat-
ment to inhibit RHAMM-mediated motility suggests
thymocytes express RHAMM as a gpi-anchored pro-
tein. Consistent with our model, motility is restored to
PLC-treated thymocytes if exogenous HA is added
because iRHAMM-5 is redistributed to the cell sur-
face. However this could also be consistent with
expression of only one isoform of RHAMM. If
sRHAMM is a gpi-anchored protein, it might cycle
from the cell surface to intracellular sites in lipid rafts
in response to HA binding and contribute to the intra-
cellular pool of RHAMM until it cycles back to the
cell surface.
Mab staining patterns indicate sRHAMM-9 and
iRHAMM-5 express different epitopes. However, one
form of RHAMM could contain both epitopes, but
Mab binding might be dependent on the conformation
RHAMM assumes in different cellular locations. For
example, at the cell surface, RHAMM might associ-
ate with the components ofHARC and assume a con-
formation hiding the 3T3-5 binding epitope while
preserving the 3T3-9 epitope. If this occurs, it would
result in negligible binding to cell surface RHAMM
by Mab 3T3-5 giving the appearance that
sRHAMM-9 and iRHAMM-5 are different isoforms
because they are specifically recognized by different
Mabs. Evidence against this possibility is that Mab
3T3-5 continues to bind to iRHAMM-5 after it is
redistributed to the cell surface where it should
assume the "cell surface’ conformation. It is plausible
that sRHAMM-5 may interact with alternative cell
surface proteins than does sRHAMM-9 when it is ini-
tially redistributed to the cell surface. This would
maintain RHAMM-5, at least transiently, in a confor-
mation that reveals the 3T3-5 epitope and hides the
3T3-9 epitope. Definitive evidence to determine
whether the two Mabs bind two distinct isoforms of
RHAMM requires expression of the previously
described RHAMM mRNA isoforms into an expres-
sion vector followed by analysis of the expressed pro-
teins.
How Do sRHAMM-9 And iRHAMM-5 Function
To Mediate Motility?
Although Mab binding profiles provide suggestive
but inconclusive evidence for the existence of two
distinct RHAMM isoforms in human thymocytes, our
motility analyses indicate sRHAMM-9 and
iRHAMM-5 function differently, supporting our
hypothesis that thymocytes express two RHAMM222 SHERYL L. GARES and LINDA M. PILARSKI
isoforms. Thymocytes treated with HAase are not
motile which indicates HA is absolutely required by
thymocytes to mediate motility. HAase-treated thy-
mocytes have the phenotype
sRHAMM-9+/sRHAMM-5 -, thus RHAMM surface
expression is not affected (unpublished observations).
The requirement for HA may indicate HA binding to
sRHAMM-9 mediates motility, generates signals or
redistributes iRHAMM-5 to the cell surface. Redis-
tributed sRHAMM-5 then mediates motility alone or
in combination with sRHAMM-9. Mab 3T3-9 inhib-
its motility in this assay system, but we do not know if
motility is inhibited directly or whether upstream
events are inhibited by Mabs binding to sRHAMM-9.
Anti-RHAMM Mabs do not block HA binding, but
may block interaction of sRHAMM-9 with other pro-
teins required to generate signals or mediate motility.
HA binding to sRHAMM results in net de-phosphor-
ylation of FAK (Hall et al., 1995), thus HA binding
may mediate signals through sRHAMM-9 and per-
haps other components of HARC. This signaling cas-
cade may initiate integrins to adopt, or maintain low
avidity binding conformations required to promote
motile behavior. If Mab 3T3-9 inhibits signaling by
sRHAMM-9, integrins will be maintained in a high
avidity conformation and adhesion becomes the dom-
inant behavior.
In contrast to Mab 3T3-9, Mab 3T3-5 blocks
RHAMM-mediated motility only in the presence of
HA. In the absence of exogenous HA, iRHAMM-5
remains inside the cell and Mab 3T3-5 cannot bind,
thus cannot inhibit motility. Synthesis of endogenous
HA during the period of Mab pre-treatment must be
insufficient to mobilize iRHAMM-5 to the cell sur-
face in sufficient quantity for Mabs to bind and cause
subsequent inhibition of motility. Most importantly,
this data indicates the absolute requirement for
RHAMM-5 to mediate motility. By extrapolation,
motile behavior requires redistribution of
iRHAMM-5 to the cell surface where it can partici-
pate in mediating motility. Interestingly, although
PLC treatment inhibits thymocyte motility, FACS
analysis of PLC-treated thymocytes indicates only a
partial decrease of staining by Mab 3T3-9. This indi-
cates sRHAMM-9 is not completely removed from
the cell surface by PLC and suggests sRHAMM-9
may not be a gpi-anchored protein. Alternatively,
intermolecular interactions of sRHAMM-9 with HA
or other surface proteins may protect the gpi anchor
from cleavage by PLC. An alternative possibility is
that PLC treatment inhibits motility by cleaving
sRHAMM-5. Thymocytes stained with Mab 3T3-5
demonstrate very weak staining profiles and this indi-
cates very low to no density of receptor at the cell sur-
face. However, PLC-treated thymocytes subsequently
stained with Mab 3T3-5 demonstrate even weaker
staining profiles in comparison to untreated cells.
Although Mab 3T3-5 demonstrates negligible stain-
ing of ex vivo thymocytes, sRHAMM-5 may be
present at very low density on most thymocytes at any
given time. iRHAMM-5 may constantly cycle from
an intracellular compartment to the cell surface per-
haps in response to low levels of endogenous HA. At
the cell surface it appears to be expressed as a
gpi-anchored protein or associates with a
gpi-anchored protein, thus is susceptible to cleavage
by PLC.
The ability of both Mabs to block motility indicates
both RHAMM isoforms are functional mediators of
motility. This suggests sRHAMM-9 and sRHAMM-5
may combine to form multimers at the cell surface
and these multimers are the functional mediators of
motility (Fig. 3C). There is indirect evidence suggest-
ing RHAMM receptors associate in multimeric com-
plexes to mediate motility. A RHAMM gene
truncated to remove the HA binding domains behaves
as a dominant suppressor ofRHAMM function when
transfected into tumorigenic cells (Hall et al., 1995).
The transfected cells become less motile and form
large stable focal adhesions indicating RHAMM
function is downregulated. These cells express wild
type RHAMM as well as mutant RHAMM, yet
mutant RHAMM dominates in mediating cellular
behavior. This suggests wild type RHAMM and
mutant RHAMM are unable to form multimers or
form multimers that are unable to function normally
because they lack the full complement ofHA binding
domains. Consistent with the idea that RHAMM only
mediates motility when it forms a multimeric com-
plex, Mab binding to either isoform of RHAMM223
might interfere with the ability of sRHAMM-9 to
associate with sRHAMM-5. Redistributed
sRHAMM-5 may combine with sRHAMM-9 in
HARC. Alternatively, sRHAMM-9 may dissociate
from this complex and combine with redistributed
sRHAMM-5 to mediate motility. This latter possibil-
ity implies sRHAMM-9 may be involved in generat-
ing signals when in association with other
components of HARC and mediates motility when in
association with sRHAMM-5. The high density of
sRHAMM-5 following HA treatment predicts
RHAMM complexes are likely to contain two or
more sRHAMM-5 receptors interacting with one
sRHAMM-9 receptor. Expression of RHAMM in a
multimeric complex is likely to increase ligand bind-
ing avidity since HA is a relatively linear, polymeric
molecule. Only multimers of the basic HA dimer
mediate motility, therefore, a multimeric association
of RHAMM-5 and RHAMM-9 may be required to
bind HA and mediate motility.
CLOSING REMARKS
This model indicates RHAMM functions to provide
thymocytes with a mechanism to rapidly alter from
sessile to motile behavior in the presence of appropri-
ate stimuli. The model also predicts that once thymo-
cytes express RHAMM, they may also express HAS
in order to maintain endogenous synthesis of HA.
Endogenous HA might be required to maintain very
low levels of surface RHAMM while cells are sessile.
An important postulate of this model is that HA bind-
ing by RHAMM either causes integrins to adopt, or
maintains integrins in, a low avidity binding confor-
mation which keeps cells in a "ready-state" for migra-
tion. Although integrins may control the balance
between adhesive and motile behavior before
RHAMM is expressed, it seems reasonable that
RHAMM should play a role in this decision once it is
expressed. Just as there is a balance between negative
and positive selection based on TCR:MHC avidity,
there is likely to be a balance between sessile and
motile behavior based on integrin avidity.
Thymocytes are required to make many "stops and
starts" as they differentiate because they must interact
with many cells within a given compartment and also
must move between compartments during maturation.
This model presents a way for cells to rapidly change
from sessile behavior to motile behavior and vice
versa, thus should fulfill the behavioral requirements
of differentiating thymocytes.
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